Research Article

The Utility of Endoscopic Biopsies in Patients with Normal Upper Endoscopy

Table 5

Yield of pathologic abnormality and cost per positive finding on macroscopically normal EGDs based on the clinical indication.

IndicationPathologic findingHistologic abnormality (%)
(absolute number)
Cost/positive finding ( CAD)

DysphagiaReflux esophagitis25% (14/56)313
Eosinophilic esophagitis11% (6/56)711

HeartburnReflux esophagitis21% (24/113)372
Eosinophilic esophagitis0% (0/113)

DyspepsiaReflux esophagitis15% (33/220)521
Chronic gastritis27% (140/520)298
HP gastritis6% (31/520)1404
Celiac disease2% (8/420)3992

AnemiaReflux esophagitis0% (0/7)
Chronic gastritis30% (29/97)268
HP gastritis15% (15/97)536
Duodenitis1% (2/151)7983
Increased IEL7% (11/151)1140
Celiac disease1% (2/151)7983

Diarrhea Increased IEL7% (6/91)1140
Celiac disease6% (5/91)1331

Nausea and vomitingReflux esophagitis7% (3/41)1117
Eosinophilic esophagitis2% (1/41)3911
Chronic gastritis24% (20/85)335
HP gastritis6% (5/85)1404

GI bleedReflux esophagitis0% (0/2)
Chronic gastritis27% (8/30)298
HP gastritis10% (3/30)803
Duodenitis5% (1/21)1597

The percentages in this table indicate the yield of an abnormality found on a macroscopically normal EGD with a targeted indication.